Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1141.04
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Sarah Elizabeth Roques has worked on the following 155 EPO patent applications which have been published in the last five years:

EP11756957

HETEROGENEOUS IMPLANTABLE DEVICES FOR DRUG DELIVERY

IPC classification:
A61K 9/22
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11733719

DIFFOCINS AND METHODS OF USE THEREOF

IPC classification:
C07K 14/33, C12N 15/09, C12N 15/75
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP11819236

METHODS FOR ENRICHING PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTE PROGENITOR CELLS AND CARDIOMYOCYTE CELLS BASED ON SIRPA EXPRESSION

IPC classification:
C12N 5/077, C12N 5/0775, C12Q 1/04, C12Q 1/68, G01N 33/567
Applicant:
University Health Network (UHN)
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11827648

NATIVE-EXTENSION PARALLEL SEQUENCING

IPC classification:
C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
The patent has been granted
EP11784896

RECOMBINANT P4 BACTERIOPHAGE AND METHODS FOR THEIR USE

IPC classification:
C12N 7/00, C12Q 1/04
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP12193435

Implantable polymeric device for sustained release of buprenorphine

IPC classification:
A61K 9/00, A61K 31/485, A61K 47/32
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11736228

NON-NATURAL MIC PROTEINS

IPC classification:
C07K 14/705, C40B 40/10, A61K 38/17
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12739836

CONJUGATES UTILIZING PLATFORM TECHNOLOGY FOR STIMULATING IMMUNE RESPONSE

IPC classification:
C07K 1/00, A61K 39/385
Applicant:
The Regents of the University of Colorado
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12744328

YEAST-BASED THERAPEUTIC FOR CHRONIC HEPATITIS B INFECTION

IPC classification:
C07K 14/02, A61K 36/06, A61K 39/29
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
The patent has been granted
EP12744776

METHODS OF PROGNOSING AND ADMINISTERING TREATMENT FOR INFLAMMATORY DISORDERS

IPC classification:
C12P 19/34
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP12702052

DIAGNOSTIC METHOD FOR URINARY TRACT INFECTION

IPC classification:
G01N 33/68
Applicant:
Hansa Medical AB
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
The patent has been granted
EP12706622

TREATMENT FOR IGE-MEDIATED DISEASE

IPC classification:
A61P 37/06, G01N 33/573, G01N 33/68, A61K 38/47
Applicant:
Hansa Medical AB
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP12709144

DENDRITIC CELLS OBTAINED FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS)

IPC classification:
C12N 5/074, C12N 5/0784
Applicant:
Oxford University Innovation Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12757534

YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS

IPC classification:
A61P 35/00, A61K 36/06, A61K 38/17, A61K 39/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP13160214

Yeast-based vaccines as immunotherapy

IPC classification:
C12N 15/62, A61K 39/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Multiple attorneys, Urquhart-Dykes & Lord LLP
Status:
EXAMINATION IN PROGRESS
EP12797077

MOLECULAR PROFILING FOR CANCER

IPC classification:
C40B 30/04
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12800096

YEAST-BASED COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF HEPATITIS DELTA VIRUS INFECTION

IPC classification:
C07K 14/02, A61K 36/06, A61K 39/29
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12834099

MOLECULAR TESTING OF MULTIPLE PREGNANCIES

IPC classification:
C12Q 1/68
Applicant:
Chinese University of Hong Kong (CUHK)
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Susan Joan Harrison, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11845367

DETECTION OF GENETIC OR MOLECULAR ABERRATIONS ASSOCIATED WITH CANCER

IPC classification:
C12Q 1/68, G06F 19/18, G06F 19/20
Applicant:
Chinese University of Hong Kong (CUHK)
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Susan Joan Harrison, Mewburn Ellis LLP
Status:
The patent has been granted
EP12753550

ASSAY FOR HISTIDINYL HYDROXYLASE ACTIVITY

IPC classification:
C12Q 1/26, G01N 33/50
Applicant:
Oxford University Innovation Ltd
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP13161985

Methods of using miRNA for detection of in vivo cell death

IPC classification:
C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Cooley (UK) LLP
Status:
The patent has been granted
EP12753801

METHOD FOR IDENTIFYING MODULATORS OF HCV TRANSLATION OR REPLICATION INVOLVING THE NS5B POLYPEPTIDE AND A PSEUDOKNOT

IPC classification:
C12Q 1/70
Applicant:
University of Edinburgh
Applicant:
University of Warwick
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12824638

YEAST-MUC1 IMMUNOTHERAPEUTIC COMPOSITIONS AND USES THEREOF

IPC classification:
A61P 35/00, C12N 1/19, C12N 15/62, C12N 15/81, C12Q 1/68
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12751657

METHODS OF TREATING PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS

IPC classification:
A61P 25/00, C07K 16/28, A61K 39/395
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Applicant:
AbbVie Biotechnology Ltd
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12832680

METHODS AND COMPOSITIONS FOR TREATING, REVERSING, INHIBITING OR PREVENTING RESISTANCE TO ANTIPLATELET THERAPY

IPC classification:
A61K 31/20
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Raymond Stevenson Gairns, AstraZeneca PLC
Status:
GRANT OF PATENT INTENDED
EP12756523

ENDOGLYCOSIDASE FROM STREPTOCOCCUS PYOGENES AND METHODS USING IT

IPC classification:
C07K 14/315, C12N 9/24, G01N 33/573, G01N 33/68, A61K 38/47
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP11872834

METHOD FOR MONITORING, DIAGNOSIS AND/OR PROGNOSIS OF ACUTE KIDNEY INJURY IN EARLY STAGE

IPC classification:
C12Q 1/00, G01N 33/00, A61K 38/00
Applicant:
University of the Andes Chile (Universidad de los Andes Chile)
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12834150

COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES

IPC classification:
C12P 1/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12839256

TREATMENT OF DEGENERATIVE JOINT DISEASE

IPC classification:
A61P 19/02, A61K 31/4965, A61K 38/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12842163

COMPOSITIONS AND METHODS FOR DIRECTIONAL NUCLEIC ACID AMPLIFICATION AND SEQUENCING

IPC classification:
C40B 50/06
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP14165468

Cancer Immunotherapy Compositions and Methods of Use

IPC classification:
C12N 15/85, A61K 35/00
Applicant:
University of California
Agent:
Hoffmann Eitle PartmbB
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12781243

METHODS OF DETECTING BRAF MUTATIONS IN CANCER

IPC classification:
C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12844064

TREATMENT OF RHINITIS

IPC classification:
A61K 31/497
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12844836

TRANSGENIC PIG MODELS OF CYSTIC FIBROSIS

IPC classification:
C07H 21/04, G01N 33/15
Applicant:
University of Iowa Research Foundation
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12851240

POPULATIONS OF HEMATOPOIETIC PROGENITORS AND METHODS OF ENRICHING STEM CELLS THEREFOR

IPC classification:
C12N 5/071, C12N 5/0789, C12Q 1/24
Applicant:
University Health Network (UHN)
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12854261

IMMUNOGENIC PLASMODIUM FALCIPARUM ANTIGEN COMPOSITIONS AND USES THEREOF

IPC classification:
A61P 37/00, A61K 39/015
Applicant:
University of California
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12799265

EXOSOMES WITH TRANSFERRIN PEPTIDES

IPC classification:
C12N 15/11, A61K 39/00, A61K 48/00
Applicant:
Oxford University Innovation Ltd
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12863862

METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS

IPC classification:
C07K 14/72, A61K 38/00, A61K 38/04, A61K 38/08
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11815647

VECTORS AND HOST CELLS COMPRISING A MODIFIED SV40 PROMOTER FOR PROTEIN EXPRESSION

IPC classification:
C07K 14/025, C07K 16/00, C12N 15/85
Applicant:
AbbVie Biotechnology Ltd
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13703174

APJ RECEPTOR COMPOUNDS

IPC classification:
C07K 7/08, A61K 38/10
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13735960

PURIFICATION OF FLAVIVIRUSES

IPC classification:
B01D 15/00, C12N 7/00, C12N 7/02
Applicant:
Sanofi Pasteur Biologics LLC
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12796933

CIRCULATING BIOMARKERS FOR CANCER

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
Caris Life Sciences Switzerland Holdings GmbH
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12841851

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ATTENTION DEFICIT HYPERACTIVITY DISORDER

IPC classification:
A01N 37/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
EXAMINATION IN PROGRESS
EP13740653

COMPOSITIONS AND METHODS FOR TARGETED NUCLEIC ACID SEQUENCE ENRICHMENT AND HIGH EFFICIENCY LIBRARY GENERATION

IPC classification:
C40B 50/06
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13716031

A METHOD OF USING ADENOSINE AND DIPYRIDAMOLE FOR PHARMACOLOGIC STRESS TESTING, WITH SPECIFIC COMPOSITIONS, UNIT DOSAGE FORMS AND KITS

IPC classification:
A61K 31/519, A61K 31/7076, A61K 51/04
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13747149

ENHANCING FERMENTATION OF STARCH-AND SUGAR-BASED FEEDSTOCKS

IPC classification:
C12N 1/16, C12N 1/20, C12P 7/10, C12P 7/20
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13749674

SYSTEMIC DELIVERY AND REGULATED EXPRESSION OF PARACRINE GENES FOR CARDIOVASCULAR DISEASES AND OTHER CONDITIONS

IPC classification:
A61P 9/00, A61P 17/00, A61K 9/06, A61K 9/08, A61K 38/16, A61K 38/17, A61K 48/00
Applicant:
University of California
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13754740

EXPANSION OF ALLOANTIGEN-REACTIVE REGULATORY T CELLS

IPC classification:
A61P 37/00, C12N 5/0781, C12N 5/0783, A61K 35/14
Applicant:
University of California
Agent:
Zacco Denmark A/S
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13751435

ANIMAL FEED COMPOSITIONS AND METHODS OF USING THE SAME

IPC classification:
A61K 31/716
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Robert Harland Games, Albright IP Limited
Agent:
Jacqueline Gail Victoria Evans, Marches Intellectual Property Ltd
Status:
GRANT OF PATENT INTENDED
EP12838801

TREATMENT OF RHINITIS

IPC classification:
A61K 31/56
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12840601

IMPLANTABLE MEDICAL DEVICES WITH INCREASED IMMUNE TOLERANCE, AND METHODS FOR MAKING AND IMPLANTING

IPC classification:
A61F 13/00, A61K 31/495, A61K 31/496, A61L 27/28, A61L 27/54, A61L 29/16, A61L 31/16
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14153848

Methods and systems of using exosomes for determining phenotypes

IPC classification:
C12Q 1/68, G01N 33/50, G01N 33/53, G01N 33/543, G01N 33/574, G01N 33/68
Applicant:
Caris Life Sciences Switzerland Holdings GmbH
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14170690

Targeting complement factor H for treatment of diseases by the sue of CR2-FH molecules

IPC classification:
C07K 14/435, A61K 38/00
Applicant:
The Regents of the University of Colorado
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11766687

CIRCULATING BIOMARKERS FOR DISEASE

IPC classification:
C12Q 1/68
Applicant:
Caris Life Sciences Switzerland Holdings GmbH
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11818814

CIRCULATING BIOMARKERS FOR DISEASE

IPC classification:
C12Q 1/68, G01N 33/50, A61K 49/00
Applicant:
Caris Life Sciences Switzerland Holdings GmbH
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION WITHDRAWN
EP12749642

CIRCULATING BIOMARKERS

IPC classification:
C12Q 1/68, G01N 33/50, G01N 33/53, G01N 33/574
Applicant:
Caris Life Sciences Switzerland Holdings GmbH
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13153098

Prostate cancer survival and recurrence

IPC classification:
C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13775895

METHODS AND SYSTEMS FOR SACCHARIFICATION OF BIOMASS

IPC classification:
C12P 7/10, C12P 19/02, C12P 19/12
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13719354

DEUTERATED RIGOSERTIB

IPC classification:
A61P 35/00, C07C 317/28, A61K 31/198
Applicant:
Concert Pharmaceuticals Inc
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13719147

ANTIBODIES AGAINST CD106 (VCAM-1)

IPC classification:
C07K 16/28, G01N 33/53
Applicant:
Oxford University Innovation Ltd
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13784151

TREATING INFLAMMATORY CONDITIONS AND IMPROVING ORAL HYGIENE USING METAL MODULATORS WITH METHYLSULFONYLMETHANE AS TRANSPORT ENHANCER

IPC classification:
A61P 1/02
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14180710

Stabilization of vaccines by lyophilization

IPC classification:
C07K 14/005, C12N 7/00, A61K 9/19, A61K 39/00, A61K 39/12
Applicant:
Sanofi Pasteur Biologics LLC
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP13791023

MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS

IPC classification:
A61K 31/713
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14178061

Therapeutic use of anti-CS1 antibodies

IPC classification:
A61P 35/00, A61P 37/00, C07K 16/28, C12N 5/20, A61K 39/395
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13801095

COMPOSITIONS AND METHODS FOR TREATING CROHN'S DISEASE AND RELATED CONDITIONS AND INFECTIONS

IPC classification:
A61P 1/00, A61P 31/04, A61K 39/395
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13794009

APPARATUSES AND METHODS FOR CONDUCTING BINDING ASSAYS

IPC classification:
G01N 1/36, G01N 33/48
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13788362

MULTI-STAGE PROCESS FOR PRODUCTION OF IMMUNE MODULATOR

IPC classification:
A61K 31/716
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Robert Harland Games, Albright IP Limited
Agent:
Jacqueline Gail Victoria Evans, Marches Intellectual Property Ltd
Agent:
Colm Damien Murphy, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP14197798

Method for the extraction of lignin from biomass

IPC classification:
C08B 37/00, C08H 7/00, C08H 8/00, C13K 1/02, C13K 13/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13806724

COMPOSITIONS AND METHODS FOR MEDIATING PLANT STOMATAL DEVELOPMENT IN RESPONSE TO CARBON DIOXIDE AND APPLICATIONS FOR ENGINEERING DROUGHT TOLERANCE IN PLANTS

IPC classification:
C07H 21/02, C07H 21/04, C07K 14/415, C12N 5/04, C12N 5/14, C12N 9/14, C12N 15/29, C12N 15/63, C12N 15/82, A01H 1/00, A01H 5/00
Applicant:
University of California
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11769448

PRODUCTS AND METHODS FOR TISSUE PRESERVATION

IPC classification:
G01N 1/00, G01N 1/30, G01N 31/00, G01N 33/48
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13739271

Method For Detecting Autoantibodies

IPC classification:
G01N 27/02, G01N 27/327, G01N 33/543, G01N 33/68
Applicant:
Oxford University Innovation Ltd
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13829413

MICROCAPSULE COMPOSITIONS AND METHODS

IPC classification:
C12P 19/34, A61K 9/50, A61K 9/52
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14197793

METHODS FOR TREATING LIGNOCELLULOSIC MATERIALS

IPC classification:
B01D 15/18, C08B 37/00, C08H 7/00, C08H 8/00, C13K 1/02, C13K 13/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14197237

Anti-VEGF Antibodies and their uses

IPC classification:
A61P 35/00, A61P 37/00, C07K 16/22, C12N 15/13, C12N 15/63, A61K 39/395, A61K 47/48
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13834427

SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION

IPC classification:
C12N 15/11, C12Q 1/68
Agent:
Carpmaels & Ransford LLP
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11756806

PHARMACOGENOMIC AND RESPONSE-GUIDED TREATMENT OF INFECTIOUS DISEASE USING YEAST-BASED IMMUNOTHERAPY

IPC classification:
C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13773582

HUMAN TOLL-LIKE RECEPTOR INHIBITORS AND METHODS OF USE THEREOF

IPC classification:
A61P 37/06, C12N 15/117, A61K 31/7115, A61K 39/39
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13843349

ALTERNATIVE PATHWAY SPECIFIC ANTIBODIES FOR TREATING HEMOLYTIC DISEASES

IPC classification:
A61P 7/04, A61P 35/00, C07K 16/40, A61K 39/395
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13776656

COMPOSTIONS AND METHODS FOR PRODUCING GLYCOPROTEINS

IPC classification:
C07K 16/00, C12N 5/07
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
The patent has been granted
EP14196416

Anti-TNF-alpha antibodies and their uses

IPC classification:
C07K 16/24
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13856610

BIOMARKER COMPOSITIONS AND METHODS

IPC classification:
C07H 21/04, C12Q 1/68, G01N 33/53, A61K 48/00
Applicant:
Caris Life Sciences Switzerland Holdings GmbH
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13805701

ANTI-VEGF ANTIBODIES AND THEIR USES

IPC classification:
C07K 16/22
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13858050

PREPARATION OF GENE-SPECIFIC TEMPLATES FOR THE USE IN SINGLE PRIMER AMPLIFICATION

IPC classification:
C12P 19/34
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13826752

USE OF ERIBULIN IN THE TREATMENT OF BREAST CANCER

IPC classification:
A61P 35/00, A61K 31/335
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13862428

METHODS AND DEVICES FOR DETECTION AND ACQUISITION OF BIOMARKERS

IPC classification:
A61M 37/00
Applicant:
The Scripps Research Institute
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13862194

METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES

IPC classification:
C12P 19/34, C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13869541

METHODS FOR TREATING GI TRACT DISORDERS

IPC classification:
A61K 31/5415
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13866160

METHOD FOR TREATMENT OF DISEASES

IPC classification:
A61K 31/58
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13860904

COMPOSITIONS AND METHODS OF NUCLEIC ACID PREPARATION AND ANALYSES

IPC classification:
C12N 15/10, C12P 19/34, C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION WITHDRAWN
EP13870568

SINGLE-STRANDED POLYNUCLEOTIDE AMPLIFICATION METHODS

IPC classification:
C12N 15/10, C12P 19/34, C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13865764

COMPOSITIONS AND METHODS FOR APTAMER SCREENING

IPC classification:
C12Q 1/68, G01N 33/566
Applicant:
Caris Life Sciences Switzerland Holdings GmbH
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15152731

Methods of treating multiple myeloma using combination therapies based on anti-CS1 antibodies

IPC classification:
A61P 35/00, A61K 31/454, A61K 31/69, A61K 38/55, A61K 39/395, A61K 45/06
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14745933

METHODS FOR PRODUCING DIKETOPIPERAZINES AND COMPOSITIONS CONTAINING DIKETOPIPERAZINES

IPC classification:
C07D 241/52, C07K 14/76, A61K 38/38
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14749595

POLYNUCLEOTIDE BARCODE GENERATION

IPC classification:
C40B 20/00, C40B 50/06
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Graham Robert Forrest, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12732095

NONINVASIVE PRENATAL GENOTYPING OF FETAL SEX CHROMOSOMES

IPC classification:
G06F 19/00
Applicant:
Chinese University of Hong Kong (CUHK)
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Susan Joan Harrison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14743593

COMPOSITIONS AND METHODS FOR GENETIC ANALYSIS OF EMBRYOS

IPC classification:
A61K 35/48
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14713570

NON-INVASIVE PRENATAL SCREENING

IPC classification:
C12Q 1/68
Applicant:
Oxford University Innovation Ltd
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14772587

METHODS AND COMPOSITIONS FOR TREATING CANCER AND INFLAMMATORY DISEASES

IPC classification:
A61P 29/00, A61P 35/00, C07K 19/00, A61K 38/10, A61K 38/16
Applicant:
The Regents of the University of Colorado
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14780393

ENRICHMENT AND NEXT GENERATION SEQUENCING OF TOTAL NUCLEIC ACID COMPRISING BOTH GENOMIC DNA AND cDNA

IPC classification:
C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14769547

METHODS, COMPOSITIONS AND KITS FOR GENERATION OF STRANDED RNA OR DNA LIBRARIES

IPC classification:
C12P 19/34, C40B 40/06
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION WITHDRAWN
EP14722414

DIFFOCINS AND METHODS OF USE THEREOF

IPC classification:
C07K 14/33, A61K 39/08
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14767480

MODULATION OF PLANT IMMUNE SYSTEM FUNCTION

IPC classification:
C07K 16/00, A01N 65/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Jacqueline Gail Victoria Evans, Marches Intellectual Property Ltd
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP14768123

METHOD AND APPARATUS FOR UNICELLULAR BIOMASS PRODUCTION USING PH CONTROL SYSTEM AND INDUSTRIAL WASTEWATER WITH HIGH BIOCHEMICAL OXYGEN DEMAND LEVELS

IPC classification:
C02F 3/30
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Colm Damien Murphy, Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP15180408

Reagents and methods for cancer treatment and prevention

IPC classification:
A61K 31/365, A61K 39/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14719988

PEPTIDE COMPOSITIONS

IPC classification:
C07K 7/54, A61K 38/12
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14770117

ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER STEM CELLS

IPC classification:
C12N 5/00, C12N 15/00, C12N 15/11, A61K 48/00
Applicant:
ANDES BIOTECHNOLOGIES S.A.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14764629

SEQUENTIAL SEQUENCING

IPC classification:
C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14770615

GENOME EDITING USING EFFECTOR OLIGONUCLEOTIDES FOR THERAPEUTIC TREATMENT

IPC classification:
C12N 15/11
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14797995

YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA

IPC classification:
A61K 39/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP11849437

CARBON DIOXIDE SEQUESTRATION IN CONCRETE ARTICLES

IPC classification:
B01D 53/62, B28B 1/087, B28B 7/18, B28B 7/44, C04B 40/02, C04B 111/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11766685

STABILIZED CHEMICAL DEHYDRATION OF BIOLOGICAL MATERIAL

IPC classification:
B01J 20/28, B32B 1/00, B32B 9/00, C07K 17/00, C12N 11/10, G01N 33/543, A01N 1/02
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11711379

DENDRITIC CELL INHIBITORY PROTEINS FROM TICKS

IPC classification:
C07K 14/435, C07K 16/00, A61K 38/17, A61K 48/00
Applicant:
Natural Environment Research Council
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14807920

COMBINATION THERAPY FOR PROSTATE CANCER USING BOTANICAL COMPOSITIONS AND DOCETAXEL

IPC classification:
A61P 35/00, A61K 36/074
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14807899

NOVEL FORMULATIONS OF BOTANICAL EXTRACTS FOR CANCER THERAPY

IPC classification:
A61K 36/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14732605

METHOD OF DETECTING THE PRESENCE OR ABSENCE OF AUTOANTIBODIES

IPC classification:
C12N 1/20
Applicant:
Oxford University Innovation Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15193910

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF

IPC classification:
C07K 16/28, C07K 17/00, A61K 39/395
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14739971

USE OF ERIBULIN AND LENVATINIB AS COMBINATION THERAPY FOR TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/357, A61K 31/47
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14818442

METHODS AND COMPOSITIONS FOR CONCRETE PRODUCTION

IPC classification:
B28C 7/02
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14747279

APJ RECEPTOR COMPOUNDS

IPC classification:
C07K 7/08, A61K 38/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11764149

DIAGNOSTIC METHOD FOR BACTERIAL MENINGITIS

IPC classification:
G01N 33/569, G01N 33/68
Applicant:
Hansa Medical AB
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15193917

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF

IPC classification:
C07K 16/28, C07K 17/00, A61K 39/395
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14844758

HYPERTONIC ANTIMICROBIAL THERAPEUTIC COMPOSITIONS

IPC classification:
A61Q 19/00, A61K 8/19, A61K 8/43
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14790863

HUMAN IPSC-DERIVED VASCULAR-RELATED AND HEMATOPOETIC CELLS FOR THERAPIES AND TOXICOLOGY/DRUG SCREENINGS

IPC classification:
C12N 5/00, C12N 5/074
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12703873

METHOD FOR ASSAYING OGFOD1 ACTIVITY

IPC classification:
C12Q 1/26, C12Q 1/34
Applicant:
Oxford University Innovation Ltd
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP14799574

EPSTEIN-BARR VIRUS VACCINES

IPC classification:
A61K 39/12
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11741678

Method for diagnosing pre-eclampsia

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
Cambridge Medical Innovations Limited
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16153921

METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS

IPC classification:
A61K 39/23
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP14860535

CELL-FREE NUCLEIC ACIDS FOR THE ANALYSIS OF THE HUMAN MICROBIOME AND COMPONENTS THEREOF

IPC classification:
C12Q 1/68, C12Q 1/70, C40B 30/04
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP13168383

Methods of treating multiple myeloma using combination therapies based on HuLuc63 with bortezomib

IPC classification:
A61P 35/00, A61K 31/454, A61K 31/573, A61K 31/69, A61K 39/395, A61K 45/06
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
James Roger Wilding, Avidity IP Ltd
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP13168364

Methods of Treating Multiple Myeloma Using Combination Therapies based on Anti-CS1 Antibodies

IPC classification:
A61P 35/00, A61K 31/454, A61K 31/69, A61K 38/55, A61K 39/395, A61K 45/06
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
James Roger Wilding, Avidity IP Ltd
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11751233

BIOMARKERS FOR THERANOSTICS

IPC classification:
C12Q 1/68, G01N 33/53
Applicant:
Caris Life Sciences Switzerland Holdings GmbH
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
PATENT GRANTED
EP15701244

ASSAY AND MEDICAMENT

IPC classification:
C12N 7/04, A61K 35/76
Applicant:
University of Warwick
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15743068

METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS

IPC classification:
A61P 1/16, A61K 35/12, A61K 39/395
Applicant:
Johns Hopkins University
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15752783

BIOPHYSICALLY SORTED OSTEOPROGENITORS FROM CULTURE EXPANDED BONE MARROW DERIVED MESENCHYMAL STROMAL CELLS (MSCS)

IPC classification:
C12N 5/074, C12N 5/0775
Applicant:
National University of Singapore
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP16169025

COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIES FOR TREATING MULTIPLE MYELOMA

IPC classification:
A61P 35/00, A61K 31/454, A61K 31/69, A61K 38/55, A61K 39/395, A61K 45/06
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
AbbVie Biotherapeutics Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
Request for examination was made
EP15758504

USE OF ERIBULIN AND MTOR INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/4523
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15710059

PROCESS FOR THE LIQUID PHASE SYNTHESIS OF H-INP-(D)BAL-(D)TRP-PHE-APC-NH2, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

IPC classification:
C07K 1/02, C07K 1/107, C07K 14/60
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15710854

USE OF DDX3X INHIBITORS FOR THE TREATMENT OF PNEUMOVIRUS INFECTIONS

IPC classification:
A61P 31/12, C07C 275/28, C07C 275/30, C07C 275/34, C07C 323/36, C07C 335/16, C07D 213/72, C07D 239/42, C12Q 1/18, A61K 31/00, A61K 31/17
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP16174817

PHARMACEUTICAL COMPOSITIONS CONTAINING CLOSTRIDIUM DIFFICILE TOXOIDS A AND B

IPC classification:
A61K 39/08, A61K 47/26
Applicant:
Sanofi Pasteur Biologics LLC
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
Request for examination was made
EP16183261

SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF

IPC classification:
C12N 9/16, A61K 38/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Richard Andrew Norman Williams, HGF Limited
Status:
Request for examination was made
EP15776226

YEAST-BASED IMMUNOTHERAPY AND TYPE I INTERFERON SENSITIVITY

IPC classification:
A61P 31/00, A61P 33/00, A61P 35/00, A61K 35/741, A61K 36/06
Applicant:
The Regents of the University of Colorado
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15788690

DIRECT IMMUNOHISTOCHEMISTRY ASSAY

IPC classification:
G01N 33/535
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15788674

ANORDRIN COMPOSITIONS AND METHODS FOR TREATING DISEASES

IPC classification:
A61P 1/16, A61P 3/04, A61P 3/06, A61P 15/12, A61P 19/10, A61P 35/00, A61K 31/56
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15792765

COMPOSITIONS AND METHODS OF ENHANCING IMMUNOGENICITY OF POLYSACCHARIDE-PROTEIN CONJUGATES

IPC classification:
A61K 39/02, A61K 39/116, A61K 39/385
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15724000

METHOD

IPC classification:
C07K 16/00, G01N 33/564, G01N 33/68
Applicant:
Oxford University Innovation Ltd
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15730984

METHOD FOR DETECTING ANTIBODY-SECRETING B CELLS SPECIFIC FOR HLA

IPC classification:
G01N 33/53
Applicant:
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15806587

HOMOGENOUS ANTIBODY DRUG CONJUGATES VIA ENZYMATIC METHODS

IPC classification:
A61K 39/00, A61K 39/385
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP16200557

HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

IPC classification:
C07K 16/28, C07K 16/30, C12P 21/08, A61K 35/00, A61K 39/395
Applicant:
Seattle Genetics, Inc.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION PUBLISHED
EP15799685

USE OF ERIBULIN AND POLY (ADP RIBOSE) POLYMERASE (PARP) INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER

IPC classification:
A01N 43/58
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15799560

USE OF ERIBULIN IN THE TREATMENT OF CANCER

IPC classification:
C12Q 1/68, A61K 31/35, A61K 31/357
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15822502

CANCER VACCINE COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
C07K 7/00, C07K 14/00, C07K 14/47, C07K 14/82
Applicant:
The University of Washington
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15831958

ANTI-OSPA ANTIBODIES AND METHODS OF USE

IPC classification:
C07K 14/20, A61K 39/00, A61K 39/02
Applicant:
University of Massachusetts
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP15753982

MYCOBACTERIUM TUBERCULOSIS PROTEINS

IPC classification:
C07K 14/35, G01N 33/569, G01N 33/68, A61K 38/16
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED
EP17154244

METHODS AND SYSTEMS OF USING EXOSOMES FOR DETERMINING PHENOTYPES

IPC classification:
C12Q 1/68
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
APPLICATION PUBLISHED
EP15833436

TREATMENT OF JOINT CONDITIONS

IPC classification:
A61P 19/02, C07D 241/08, A61K 38/38
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature